Volunteers in UK to be injected with Coronavirus to experiment vaccine | UK Market Update

September 26, 2020 12:26 AM NZST | By Team Kalkine Media

London to be the host of the world’s first ever Covid-19 human challenge trials where healthy volunteers are deliberately infected with the virus to check the effectiveness of vaccines to experiment. The UK government-funded experiment will begin in January at a secure quarantine facility. The researchers, said the trials are likely to move into clinical testing next year. Volunteers will be injected with a vaccine and after a month, will given a dose of the virus that causes Covid-19, under controlled conditions. About 2,000 volunteers have signed up for challenge studies in the UK.

The Cinema world has raised concerns for the survival of a second lockdown, reporting a £1.3bn loss for the first half of the year because of the pandemic. The cinema‘s loss for 6 months compared it’s profits worth £110m last year, following the forced lockdown of its 778 cinemas worldwide, said admissions have been growing since it’s reopening in the UK and the US with local films and the release of the blockbuster movie Tenet. Cineworld reopened 561 cinemas. However, if there will be any further restrictions, there could be a big question about the financial future.

Nongfu Spring, Owner of China’s largest bottled water maker has overtaken Alibaba’s Jack Ma, becoming nation’s richest person, after the company’s share price shoots to $58.7bn making him richer than Mr Ma, whose fortune dipped to $56.7bn after shares in Alibaba fell 0.9% in New York recently. Investors are giving the stocks of Nongfu very high valuation, none have seen in the past.


Disclaimer

The content on this website, including, but not limited to, any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (“Content”) is a service provided by Kalkine Media New Zealand Limited (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide financial advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests users seek financial advice from a financial advice provider, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all liability to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without any express or implied warranties of any kind. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit a source wherever it is indicated or is found to be necessary or desirable.

Sponsored Articles


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.